Literature DB >> 11875610

The importance of orthotopic liver transplantation in acute hepatic failure.

Sjoerd de Rave1, Hugo W Tilanus, Joke van der Linden, Robert A de Man, Bart van der Berg, Wim C J Hop, Jan N M Ijzermans, Pieter E Zondervan, Herold J Metselaar.   

Abstract

Selection of patients with acute hepatic failure for liver transplantation remains difficult, and there is no definite proof of a survival effect. We therefore did a retrospective study in 75 consecutive patients referred over a 12-year period. In two-thirds we identified a cause, mostly viruses or drugs. Patients were grouped by the Clichy and King's College criteria. In 20 there was no indication for transplantation. Of the 5 with autoimmune hepatitis, 3 died, significantly differing from the other 15 ( P = 0.009). The remaining 55 met our criteria, except 1. All 9 patients with absolute contraindications died. Of the 46 enlisted, 7 died without transplantation. One-year survival after transplantation was 69%, compared with 58% by "intention to treat." For patients enlisted, transplantation reduced mortality by 78% ( P = 0.069). The Clichy and King's College criteria reliably predict survival without transplantation, except in autoimmune hepatitis. Our study strongly suggests that transplantation improves survival.

Entities:  

Mesh:

Year:  2002        PMID: 11875610     DOI: 10.1007/s00147-001-0369-6

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  7 in total

1.  A Macaca mulatta model of fulminant hepatic failure.

Authors:  Ping Zhou; Jie Xia; Gang Guo; Zi-Xing Huang; Qiang Lu; Li Li; Hong-Xia Li; Yu-Jun Shi; Hong Bu
Journal:  World J Gastroenterol       Date:  2012-02-07       Impact factor: 5.742

2.  Three-dimensional numerical modeling and computational fluid dynamics simulations to analyze and improve oxygen availability in the AMC bioartificial liver.

Authors:  Guy Mareels; Paul P C Poyck; Sunny Eloot; Robert A F M Chamuleau; Pascal R Verdonck
Journal:  Ann Biomed Eng       Date:  2006-10-10       Impact factor: 3.934

Review 3.  Extracorporeal bioartificial liver for treating acute liver diseases.

Authors:  Ashok Kumar; Anuj Tripathi; Shivali Jain
Journal:  J Extra Corpor Technol       Date:  2011-12

4.  Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease.

Authors:  Stefano Targhetta; Federico Villamil; Paolo Inturri; Patrizia Pontisso; Stefano Fagiuoli; Umberto Cillo; Attilio Cecchetto; Simona Gianni; Remo Naccarato; Patrizia Burra
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

5.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 6.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 7.  Pig liver xenotransplantation as a bridge to allotransplantation: which patients might benefit?

Authors:  Burcin Ekser; Bruno Gridelli; A Joseph Tector; David K C Cooper
Journal:  Transplantation       Date:  2009-11-15       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.